Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-β precursor protein

Human Molecular Genetics

Volumn 20, Issue 10, 2011, Pages 2026-2036

  Chapuis, Julien ^a   Vingtdeux, Valérie ^a   Campagne, Fabien ^b   Davies, Peter ^a,c   Marambaud, Philippe ^a,c  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CARRIER PROTEIN; GROWTH ARREST SPECIFIC 1 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC LINKAGE; GLYCOSYLATION; GOLGI COMPLEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MALE; MOUSE; MULTIVESICULAR BODY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REGULATORY MECHANISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL CYCLE PROTEINS; CELL LINE; ENDOPLASMIC RETICULUM; FEMALE; GENE ORDER; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLATION; GOLGI APPARATUS; GPI-LINKED PROTEINS; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 79955391954     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr085     Document Type: Article

References (57)

1. Selkoe, D.J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 81, 741-766.
2. Citron, M. (2010) Alzheimer's disease: strategies for disease modification. Nat. Rev. Drug Discov., 9, 387-398.
3. Querfurth, H.W. and LaFerla, F.M. (2010) Alzheimer's disease. N. Engl. J. Med., 362, 329-344.
4. Braak, H. and Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., 82, 239-259.
5. de Leon, M.J., Mosconi, L., Blennow, K., DeSanti, S., Zinkowski, R., Mehta, P.D., Pratico, D., Tsui, W., Saint Louis, L.A., Sobanska, L. et al. (2007) Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann. N. Y. Acad. Sci., 1097, 114-145.
6. Duyckaerts, C., Delatour, B. and Potier, M.C. (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol., 118, 5-36.
7. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev., 33, 95-130.
8. Checler, F. (1995) Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem., 65, 1431-1444.
9. Wilquet, V. and De Strooper, B. (2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr. Opin. Neurobiol., 14, 582-588.
10. Marambaud, P. and Robakis, N.K. (2005) Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. Genes Brain Behav., 4, 134-146.
11. Ertekin-Taner, N. (2010) Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimers Res. Ther., 2, 3.
12. Lambert, J.C. and Amouyel, P. (2007) Genetic heterogeneity of Alzheimer's disease: complexity and advances. Psychoneuroendocrinology, 32 (Suppl. 1), S62-S70.
13. Nixon, R.A. (2005) Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol. Aging, 26, 373-382.
14. Sannerud, R. and Annaert, W. (2009) Trafficking, a key player in regulated intramembrane proteolysis. Semin. Cell Dev. Biol., 20, 183-190.
15. Thinakaran, G. and Koo, E.H. (2008) Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem., 283, 29615-29619.
16. Skrabanek, L. and Campagne, F. (2001) TissueInfo: high-throughput identification of tissue expression profiles and specificity. Nucleic Acids Res., 29, E102.
17. Aguilar, D., Skrabanek, L., Gross, S.S., Oliva, B. and Campagne, F. (2008) Beyond tissueInfo: functional prediction using tissue expression profile similarity searches. Nucleic Acids Res., 36, 3728-3737.
18. Dreses-Werringloer, U., Lambert, J.C., Vingtdeux, V., Zhao, H., Vais, H., Siebert, A., Jain, A., Koppel, J., Rovelet-Lecrux, A., Hannequin, D. et al. (2008) A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell, 133, 1149-1161.
19. Boada, M., Antunez, C., Lopez-Arrieta, J., Galan, J.J., Moron, F.J., Hernandez, I., Marin, J., Martinez-Lage, P., Alegret, M., Carrasco, J.M. et al. (2010) CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. J. Alzheimers Dis., 20, 247-251.
20. Minster, R.L., Demirci, F.Y., DeKosky, S.T. and Kamboh, M.I. (2009) No association between CALHM1 variation and risk of Alzheimer disease. Hum. Mutat., 30, E566-E569.
21. Li, H., Wetten, S., Li, L., St Jean, P.L., Upmanyu, R., Surh, L., Hosford, D., Barnes, M.R., Briley, J.D., Borrie, M. et al. (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol., 65, 45-53.
22. Lambert, J.C., Sleegers, K., Gonzalez-Perez, A., Ingelsson, M., Beecham, G.W., Hiltunen, M., Combarros, O., Bullido, M.J., Brouwers, N., Bettens, K. et al. (2010) The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J. Alzheimers Dis., 22, 247-255.
23. Martinelli, D.C. and Fan, C.M. (2007) The role of Gas1 in embryonic development and its implications for human disease. Cell Cycle, 6, 2650-2655.
24. Del Sal, G., Ruaro, M.E., Philipson, L. and Schneider, C. (1992) The growth arrest-specific gene, gas1, is involved in growth suppression. Cell, 70, 595-607.
25. Lee, K.K., Leung, A.K., Tang, M.K., Cai, D.Q., Schneider, C., Brancolini, C. and Chow, P.H. (2001) Functions of the growth arrest specific 1 gene in the development of the mouse embryo. Dev. Biol., 234, 188-203.
26. Schneider, C., King, R.M. and Philipson, L. (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell, 54, 787-793.
27. Marques, G. and Fan, C.M. (2002) Growth arrest specific gene 1: a fuel for driving growth in the cerebellum. Cerebellum, 1, 259-263.
28. Kang, J.S., Zhang, W. and Krauss, R.S. (2007) Hedgehog signaling: cooking with Gas1. Sci. STKE, 2007, pe50.
29. Schueler-Furman, O., Glick, E., Segovia, J. and Linial, M. (2006) Is GAS1 a co-receptor for the GDNF family of ligands? Trends Pharmacol. Sci., 27, 72-77.
30. Cabrera, J.R., Sanchez-Pulido, L., Rojas, A.M., Valencia, A., Manes, S., Naranjo, J.R. and Mellstrom, B. (2006) Gas1 is related to the glial cell-derived neurotrophic factor family receptors alpha and regulates ret signaling. J. Biol. Chem., 281, 14330-14339.
31. Mellstrom, B., Cena, V., Lamas, M., Perales, C., Gonzalez, C. and Naranjo, J.R. (2002) Gas1 is induced during and participates in excitotoxic neuronal death. Mol. Cell. Neurosci., 19, 417-429.
32. Hamshere, M.L., Holmans, P.A., Avramopoulos, D., Bassett, S.S., Blacker, D., Bertram, L., Wiener, H., Rochberg, N., Tanzi, R.E., Myers, A. et al. (2007) Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease. Hum. Mol. Genet., 16, 2703-2712.
33. Lambert, J.C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M.J., Tavernier, B. et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet., 41, 1094-1099.
34. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A. et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet., 41, 1088-1093.
35. Su, D. and Gudas, L.J. (2008) Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells. Biochem. Pharmacol., 75, 1129-1160.
36. Lopez-Ramirez, M.A., Dominguez-Monzon, G., Vergara, P. and Segovia, J. (2008) Gas1 reduces ret tyrosine 1062 phosphorylation and alters GDNF-mediated intracellular signaling. Int. J. Dev. Neurosci., 26, 497-503.
37. Klausner, R.D., Donaldson, J.G. and Lippincott-Schwartz, J. (1992) Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol., 116, 1071-1080.
38. Haass, C., Lemere, C.A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L. and Selkoe, D.J. (1995) The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat. Med., 1, 1291-1296.
39. Bonnon, C., Wendeler, M.W., Paccaud, J.P. and Hauri, H.P. (2010) Selective export of human GPI-anchored proteins from the endoplasmic reticulum. J. Cell. Sci., 123, 1705-1715.
40. Mayor, S. and Riezman, H. (2004) Sorting GPI-anchored proteins. Nat. Rev. Mol. Cell Biol., 5, 110-120.
41. Sevlever, D., Pickett, S., Mann, K.J., Sambamurti, K., Medof, M.E. and Rosenberry, T.L. (1999) Glycosylphosphatidylinositol-anchor intermediates associate with triton-insoluble membranes in subcellular compartments that include the endoplasmic reticulum. Biochem. J., 343 (Pt 3), 627-635.
42. Perez, R.G., Soriano, S., Hayes, J.D., Ostaszewski, B., Xia, W., Selkoe, D.J., Chen, X., Stokin, G.B. and Koo, E.H. (1999) Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J. Biol. Chem., 274, 18851-18856.
43. Vingtdeux, V., Hamdane, M., Loyens, A., Gele, P., Drobeck, H., Begard, S., Galas, M.C., Delacourte, A., Beauvillain, J.C., Buee, L. et al. (2007) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J. Biol. Chem., 282, 18197-18205.
44. King, G.D. and Scott Turner, R. (2004) Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk? Exp. Neurol., 185, 208-219.
45. Miller, C.C., McLoughlin, D.M., Lau, K.F., Tennant, M.E. and Rogelj, B. (2006) The X11 proteins, Abeta production and Alzheimer's disease. Trends Neurosci., 29, 280-285.
46. Parisiadou, L. and Efthimiopoulos, S. (2007) Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11alpha. Neurobiol. Aging, 28, 377-388.
47. Small, S.A. and Gandy, S. (2006) Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron, 52, 15-31.
48. Huttunen, H.J., Guenette, S.Y., Peach, C., Greco, C., Xia, W., Kim, D.Y., Barren, C., Tanzi, R.E. and Kovacs, D.M. (2007) HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. J. Biol. Chem., 282, 28285-28295.
49. Hazane, F., Valenti, K., Sauvaigo, S., Peinnequin, A., Mouret, C., Favier, A. and Beani, J.C. (2005) Ageing effects on the expression of cell defence genes after UVA irradiation in human male cutaneous fibroblasts using cDNA arrays. J. Photochem. Photobiol. B., 79, 171-190.
50. Herrup, K. and Arendt, T. (2002) Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J. Alzheimers Dis., 4, 243-247.
51. Conejero-Goldberg, C., Hyde, T.M., Chen, S., Dreses-Werringloer, U., Herman, M.M., Kleinman, J.E., Davies, P. and Goldberg, T.E. (in press) Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype. Mol. Psychiatry, doi: 10.1038/mp.2010.57. Epub ahead of print May 18, 2010.
52. Andorfer, C., Acker, C.M., Kress, Y., Hof, P.R., Duff, K. and Davies, P. (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci., 25, 5446-5454.
53. Zhao, H., Dreses-Werringloer, U., Davies, P. and Marambaud, P. (2008) Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants. BMC Res. Notes, 1, 38.
54. Marambaud, P., Zhao, H. and Davies, P. (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem., 280, 37377-37382.
55. Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J.E., Janle, E.M., Lobo, J., Ferruzzi, M.G., Davies, P. et al. (2010) AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem., 285, 9100-9113.
56. Vingtdeux, V., Chandakkar, P., Zhao, H., d'Abramo, C., Davies, P. and Marambaud, P. (2011) Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. FASEB J., 25, 219-231.
57. Chapuis, J., Hot, D., Hansmannel, F., Kerdraon, O., Ferreira, S., Hubans, C., Maurage, C.A., Huot, L., Bensemain, F., Laumet, G. et al. (2009) Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol. Psychiatry, 14, 1004-1016.